Nasal-type Nk T-cell Lymphoma
📧 Sign up to get email alerts when something new happens for Nasal-type Nk T-cell Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-06-09Clinical Trial Update: Combined Treatment of Sintilimab, Peg-aspargase Plus Anlotinib in NK/T Cell Lymphoma [Phase 2]
A Phase 2 trial evaluating a combination of sintilimab, peg-aspargase, and anlotinib for Natural Killer/T-Cell Lymphoma (nasal/nasal-type) h…